Société des Industries Pharmaceutiques de Tunisie - S.A.'s latest marketcap:
As of 06/08/2025, Société des Industries Pharmaceutiques de Tunisie - S.A.'s market capitalization has reached $3.37 M. According to our data, Société des Industries Pharmaceutiques de Tunisie - S.A. is the 44565th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $3.37 M |
| Revenue (ttm) | $6.87 M |
| Net Income (ttm) | $-5,808,261.22 |
| Shares Out | 1.8 M |
| EPS (ttm) | $-3.23 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Société des Industries Pharmaceutiques de Tunisie - S.A.'s yearly market capitalization.
| Date | Market Cap(TND) | Change (%) |
|---|---|---|
| 06/08/2025 | 9.92 M | 25.23% |
| 12/20/2024 | 7.92 M | 17.02% |
| 12/29/2023 | 6.77 M | -8.52% |
| 11/30/2022 | 7.4 M | -26.61% |
| 12/14/2021 | 10.08 M | 45.83% |
| 12/31/2020 | 6.91 M |
Company Profile
About Société des Industries Pharmaceutiques de Tunisie - S.A.
Société des Industries Pharmaceutiques de Tunisie - S.A. is a pharmaceutical company specializing in the research, development, manufacturing, packaging, and marketing of human-use pharmaceutical products. Operating in Tunisia and internationally, the company delivers a range of therapeutic solutions.
Key Offerings
- Rheumatology Drugs: MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE.
- Stomatology Drugs: HEXABAIN.
- Pain Management: ANALGAN CODEINE 300mg/25mg for moderate to intense pain relief.
Company Background
Founded in 1989, the company is headquartered in Ben Arous, Tunisia.
Frequently Asked Questions
-
What is Société des Industries Pharmaceutiques de Tunisie - S.A.'s (BVMT-SIPHA) current market cap?As of 06/08/2025, Société des Industries Pharmaceutiques de Tunisie - S.A. (including the parent company, if applicable) has an estimated market capitalization of $3.37 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT-SIPHA) rank globally by market cap?Société des Industries Pharmaceutiques de Tunisie - S.A. global market capitalization ranking is approximately 44565 as of 06/08/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.